Efficient targeted anticoagulant with active RGD motif.

Qun Bi,Xue Zhou,Xiaodong Cen,Hong Qu,Jingchu Luo,Yixiu Huang,Shenggeng Zhu

DOI: https://doi.org/10.1016/j.thromres.2006.11.013

IF: 10.407

2007-01-01

Thrombosis Research

Abstract:Three anticoagulants combining large peptide recombinant hirudin variants (rHV2-K47) and Arg-Gly-Asp (RGD) motif related to platelet aggregation were generated, i.e. sequences CRFPRGDADPYCE and CNPRGDFRCI were added to the C-terminus of hirudin to obtain RGD-hirudin 1 and 2, respectively, and the sequence RGDSE was inserted between residues 53-54 of hirudin to obtain RGD-hirudin 3. All products exhibited antithrombin and antiplatelet activities, especially IC50 of RGD-hirudin 1 and 2 were much lower with respect to previously reported similar peptides. Our data suggested that RGD-hirudin 1 and 2 would be promising anticoagulants in clinic. Moreover, the triangular structure of active RGD was shown by computer simulation, which might contribute to our understanding on integrin-related peptides and proteins.